Nicholas D P Cosford

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

Journal of medicinal chemistry

Molecular cancer research : MCR

ACS pharmacology & translational science

Sanford Burnham Prebys Medical Discovery Institute

University of Bath (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanford Burnham Prebys Medical Discovery Institute

United States

Deputy Director :: Cancer Center

Education History

University of Bath

United Kingdom

PHD :: Organic Chemistry

Publications

Seemana Bhattacharya, Sujan Piya, Huaxian Ma, Priyanka Sharma, Qi Zhang, Natalia Baran, Vivian R Ruvolo, Teresa McQueen, Richard Eric Davis, Rasoul Pourebrahim, Marina Y Konopleva, Hagop M Kantarjian, Nicholas D P Cosford, Michael Andreeff, Gautam Borthakur
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia. Molecular cancer research : MCR (2023)
Nicole Bata, Apirat Chaikuad, Nicole A Bakas, Allison S Limpert, Lester J Lambert, Douglas J Sheffler, Lena Marie Berger, Guoxiong Liu, Cunxiang Yuan, Li Wang, Yi Peng, Jing Dong, Maria Celeridad, Fabiana Layng, Stefan Knapp, Nicholas D P Cosford
Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. Journal of medicinal chemistry (2021)
Nicole Bata, Nicholas D P Cosford
Cell Survival and Cell Death at the Intersection of Autophagy and Apoptosis: Implications for Current and Future Cancer Therapeutics. ACS pharmacology & translational science 4 (6) (2021)
Huiyu Ren, Nicole A Bakas, Mitchell Vamos, Apirat Chaikuad, Allison S Limpert, Carina D Wimer, Sonja N Brun, Lester J Lambert, Lutz Tautz, Maria Celeridad, Douglas J Sheffler, Stefan Knapp, Reuben J Shaw, Nicholas D P Cosford
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer. Journal of medicinal chemistry 63 (23) (2020)

Nicholas D P Cosford.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas D P Cosford